Elsevier’s 2027 Intravenous Medications

**Selected for 2026 Doody's Core Titles as an Essential Purchase in Medical/Surgical** Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more 50-year history of impeccable accuracy reinforces the importance of safe IV drug administration Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread

About this item

• Page count used for pricing: 1344 pages.
• A specialist title for study, reference, or professional development.

Specifications